These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19142475)

  • 1. [Oophorectomy during pelvic surgery for benign disease in perimenopausal women].
    Aldrighi JM; Ribeiro AL; Aoki T
    Rev Bras Ginecol Obstet; 2008 Feb; 30(2):51-4. PubMed ID: 19142475
    [No Abstract]   [Full Text] [Related]  

  • 2. Current knowledge of risks and benefits of prophylactic oophorectomy at hysterectomy for benign disease in United Kingdom and Republic of Ireland.
    Das N; Kay VJ; Mahmood TA
    Eur J Obstet Gynecol Reprod Biol; 2003 Jul; 109(1):76-9. PubMed ID: 12818449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy.
    Aziz A; Bergquist C; Brännström M; Nordholm L; Silfverstolpe G
    Acta Obstet Gynecol Scand; 2005 Sep; 84(9):854-9. PubMed ID: 16097975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.
    Asante A; Whiteman MK; Kulkarni A; Cox S; Marchbanks PA; Jamieson DJ
    Obstet Gynecol; 2010 Nov; 116(5):1088-95. PubMed ID: 20966693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is incidental prophylactic oophorectomy an acceptable means to reduce the incidence of ovarian cancer?
    Rozario D; Brown I; Fung MF; Temple L
    Am J Surg; 1997 Jun; 173(6):495-8. PubMed ID: 9207161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?
    Vercellini P; Viganò P; Buggio L; Makieva S; Scarfone G; Cribiù FM; Parazzini F; Somigliana E
    Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():151-168. PubMed ID: 29551389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsequent Oophorectomy and Ovarian Cancer after Hysterectomy for Benign Gynecologic Conditions at Chiang Mai University Hospital.
    Jitkunnatumkul A; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2016; 17(8):3845-8. PubMed ID: 27644627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting prophylactic oophorectomy in postmenopausal women.
    Gross CP; Nicholson W; Powe NR
    Obstet Gynecol; 1999 Dec; 94(6):962-8. PubMed ID: 10576183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prophylactic oophorectomy. An unsolved problem].
    Salvatores M; Mage G; Wattiez A
    Minerva Ginecol; 2007 Oct; 59(5):549-52. PubMed ID: 17912181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oophorectomy per occasionem and ovarian cancer].
    Madsen EM; Lidegaard O; Tabor A
    Ugeskr Laeger; 1992 Nov; 154(46):3221-5. PubMed ID: 1462422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being.
    Aziz A; Brännström M; Bergquist C; Silfverstolpe G
    Fertil Steril; 2005 Apr; 83(4):1021-8. PubMed ID: 15820815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of management options for women with a hereditary predisposition to ovarian cancer.
    Rosen B; Kwon J; Fung Kee Fung M; Gagliardi A; Chambers A;
    Gynecol Oncol; 2004 May; 93(2):280-6. PubMed ID: 15099934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal production of human chorionic gonadotropin in perimenopausal and menopausal women and after oophorectomy.
    Cole LA; Khanlian SA; Muller CY
    Int J Gynecol Cancer; 2009 Dec; 19(9):1556-9. PubMed ID: 19994471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management Strategies for the Ovaries at the Time of Hysterectomy for Benign Disease.
    Matthews CA
    Obstet Gynecol Clin North Am; 2016 Sep; 43(3):539-49. PubMed ID: 27521883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive use in perimenopause.
    Kaunitz AM
    Am J Obstet Gynecol; 2001 Aug; 185(2 Suppl):S32-7. PubMed ID: 11521120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Should we remove the tubes during surgery for benign diseases?].
    Lécuru F
    Gynecol Obstet Fertil; 2013 Nov; 41(11):625-6. PubMed ID: 24210775
    [No Abstract]   [Full Text] [Related]  

  • 17. Solo surgeon single-port laparoscopic surgery with a homemade laparoscope-anchored instrument system in benign gynecologic diseases.
    Yang YS; Kim SH; Jin CH; Oh KY; Hur MH; Kim SY; Yim HS
    J Minim Invasive Gynecol; 2014; 21(4):695-701. PubMed ID: 24509292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Profits of post-menopausal ovarian conservation at the time of hysterectomy for benign disease: mirage or reality?].
    Ouldamer L; Marret H; Jacquet A; Denakpo J; Body G
    J Gynecol Obstet Biol Reprod (Paris); 2013 Apr; 42(2):123-9. PubMed ID: 23201029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worsening of menopausal flushes after prophylactic oophorectomy.
    Poulose T; Ashelby L; Fox R
    J Obstet Gynaecol; 2006 Jul; 26(5):481-2. PubMed ID: 16846894
    [No Abstract]   [Full Text] [Related]  

  • 20. Should the ovaries be removed or retained at the time of hysterectomy for benign disease?
    Hickey M; Ambekar M; Hammond I
    Hum Reprod Update; 2010; 16(2):131-41. PubMed ID: 19793841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.